Patient-reported outcomes: active surveillance vs radical therapies in low-risk prostate cancer
Uro-Oncology
Related content
COMMENTED
Uro-Oncology
Effects of Enzalutamide on the Sexual Activity of Patients with Biochemically Recurrent Prostate Cancer: A Post Hoc Analysis of Patient-reported Outcomes in the EMBARK Study
★ 1
Recommended and commented by
Prof. Dr Richard Cathomas, Faculty Member
Eur Urol
Freedland SJ, Mulhall JP, Gleave M, Giorgi U, Saad F, Rannikko A, Ivanova JI, Nasr AF, Reisman AL, Ganguli A, Kral P, Turnbull J, Shore N
doi: 10.1016/j.eururo.2025.02.006
Further Publications Urology
Impact of Holmium Laser Enucleation of the Prostate on Active Surveillance for Prostate Cancer in Patients With Lower Urinary Tract Symptoms
Prostate
Bâcle C, Mazancourt ES, Abid N, Ruffion A, Rouvière O, Colombel M, Fassi-Fehri H
doi: 10.1002/pros.24906
Uro-Oncology
Active Surveillance for Screen-detected Low- and Intermediate-risk Prostate Cancer: Extended Follow-up up to 25 Years in the GÖTEBORG-1 Trial
Eur Urol
Palmstedt E, Månsson M, Hugosson J, Arnsrud Godtman R
doi: 10.1016/j.eururo.2025.06.012
Uro-Oncology
Positive surgical margin and oncological outcomes after robot-assisted radical prostatectomy in different Cancer of the Prostate Risk Assessment risk groups
BJU Int
Hagman A, Lantz A, Grannas D, Carlsson S, Akre O, Olsson M, Egevad L, Höijer J, Wiklund P
doi: 10.1111/bju.16732
Uro-Oncology
Prospective study of endogenous testosterone recovery following neoadjuvant hormonal blockade and radical prostatectomy in high-risk prostate cancer patients
J Sex Med
Nascimento BCG, Pedrenho R, Zandoná PCE, Sanvido LV, Bessa Junior J, Miranda EP, Bastos DA, Cordeiro MD, Coelho R, Nahas WC, Hallak J, Mulhall JP, Gomes CM
doi: 10.1093/jsxmed/qdaf164
COMMENTED
Uro-Oncology
Persistent Prostate-Specific Antigen Following Radical Prostatectomy for Prostate Cancer and Mortality Risk
★ 1
Recommended and commented by
Prof. Dr Richard Cathomas, Faculty Member
JAMA Oncol
Tilki D, Chen MH, Wu J, Huland H, Graefen M, Trock BJ, Han M, D'Amico AV
doi: 10.1001/jamaoncol.2025.0110
Uro-Oncology
History of Vasectomy Is not Associated With Prostate Cancer Progression in Men on Active Surveillance
Prostate
Grutman AJ, Jing Y, Ng DK, Landis PK, Trock BJ, Pavlovich CP
doi: 10.1002/pros.70001
Benign Prostatic Hyperplasia (BPH)
Rezūm water vapor therapy vs. thulium laser enucleation for the treatment of benign prostatic hyperplasia in patients with large prostates: a multicenter prospective comparative study
Prostate Cancer Prostatic Dis
Manfredi C, Spirito L, Quattrone C, Bottone F, Romano L, Balsamo R, Trama F, Crocetto F, Barone B, Napolitano L, Pandolfo SD, Franco A, Ditonno F, Uricchio F, Di Lauro G, Fusco F, Romero-Otero J, De Nunzio C, Autorino R, De Sio M, Arcaniolo D
doi: 10.1038/s41391-025-00971-y
Uro-Oncology
Outcome of Subsequent Therapies After (177)Lu-Vipivotide Tetraxetan for Metastatic Castrate-Resistant Prostate Cancer: A Tertiary Cancer Center Experience
Prostate
Losee M, Kavanaugh M, Liu M, Borges N, Haberman V, Ritzer J, Wolanski A, Bhimaniya S, Choudhury AD, Hyun H, Stoltenberg H, Kilbridge KL, Morgans A, Pomerantz M, Robertson M, Sakellis C, Shah H, Taplin ME, Wei XX, Ng T, Ravi P, Jacene H
doi: 10.1002/pros.24880